SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-24-002692
Filing Date
2024-01-31
Accepted
2024-01-31 16:16:05
Documents
15
Period of Report
2024-01-30
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 FORM 8-K clnn20240130_8k.htm   iXBRL 8-K 30371
  Complete submission text file 0001437749-24-002692.txt   184150

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA clnn-20240130.xsd EX-101.SCH 3943
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE clnn-20240130_def.xml EX-101.DEF 13901
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE clnn-20240130_lab.xml EX-101.LAB 18364
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE clnn-20240130_pre.xml EX-101.PRE 13933
16 EXTRACTED XBRL INSTANCE DOCUMENT clnn20240130_8k_htm.xml XML 5061
Mailing Address 6550 SOUTH MILLROCK DRIVE, SUITE G50 SALT LAKE CITY UT 84121
Business Address 6550 SOUTH MILLROCK DRIVE, SUITE G50 SALT LAKE CITY UT 84121 801-676-9695
Clene Inc. (Filer) CIK: 0001822791 (see all company filings)

IRS No.: 852828339 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39834 | Film No.: 24583103
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)